National guidelines for treatment of jaundice in the newborn

D Bratlid, B Nakstad, TWR Hansen - Acta Paediatrica, 2011 - Wiley Online Library
D Bratlid, B Nakstad, TWR Hansen
Acta Paediatrica, 2011Wiley Online Library
Jaundice is the most common reason for instituting treatment in otherwise healthy as well as
sick newborn infants. Herein, we describe the process employed in Norway to forge
agreement on a set of treatment guidelines that are now used across the country. The
Norwegian Pediatric Association was a key resource in this process, which involved
contacts with all paediatric departments in Norway. We have also performed an international
survey regarding the use of such national guidelines, showing that the majority of those …
Abstract
Jaundice is the most common reason for instituting treatment in otherwise healthy as well as sick newborn infants. Herein, we describe the process employed in Norway to forge agreement on a set of treatment guidelines that are now used across the country. The Norwegian Pediatric Association was a key resource in this process, which involved contacts with all paediatric departments in Norway.
We have also performed an international survey regarding the use of such national guidelines, showing that the majority of those queried confirm having national guidelines.
The evidence base for any neonatal jaundice guideline is weak; therefore, it is not surprising that the various guidelines differ both in format and in specifics. In the Norwegian guidelines, treatment indications are based on bilirubin concentrations and related to birth weight. Postnatal age is also factored in because jaundice develops gradually during the first 3–4 days before it levels off.
Conclusion:  Following the introduction of these guidelines, fewer babies in Norway receive phototherapy, and no cases of chronic kernicterus have been reported during this period.
Wiley Online Library
以上显示的是最相近的搜索结果。 查看全部搜索结果